Pressure Biosciences Inc (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,858 | -16,077 | -11,618 | -7,156 | -4,240 |
| Depreciation Amortization | 643 | 1,898 | 1,846 | 1,519 | 853 |
| Accounts receivable | -97 | -141 | -12 | -162 | -137 |
| Accounts payable and accrued liabilities | 132 | 109 | 80 | 25 | 137 |
| Other Working Capital | 723 | 3,023 | 2,139 | 996 | 688 |
| Other Operating Activity | 5,034 | 6,709 | 4,514 | 2,780 | 1,942 |
| Operating Cash Flow | $-422 | $-4,478 | $-3,051 | $-1,998 | $-756 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -21 | -21 | -5 | -1 |
| Investing Cash Flow | $-3 | $-21 | $-21 | $-5 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,175 | 2,710 | 5,243 | 3,289 | 351 |
| Debt Issued | 88 | 5,774 | 763 | 465 | 1,001 |
| Debt Repayment | N/A | -1,838 | -1,087 | -865 | -324 |
| Common Stock Issued | 181 | 42 | 17 | 17 | N/A |
| Other Financing Activity | -2,784 | -2,318 | -1,766 | -913 | -284 |
| Financing Cash Flow | $660 | $4,370 | $3,171 | $1,992 | $744 |
| Beginning Cash Position | 4 | 132 | 132 | 132 | 132 |
| End Cash Position | 239 | 4 | 231 | 122 | 119 |
| Net Cash Flow | $235 | $-128 | $99 | $-11 | $-14 |
| Free Cash Flow | |||||
| Operating Cash Flow | -422 | -4,478 | -3,051 | -1,998 | -756 |
| Capital Expenditure | -3 | -21 | -21 | -5 | -1 |
| Free Cash Flow | -425 | -4,499 | -3,072 | -2,003 | -757 |